Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orchestra BioMed Holdings (OBIO) Long-Term Investments (2022 - 2025)

Historic Long-Term Investments for Orchestra BioMed Holdings (OBIO) over the last 4 years, with Q3 2025 value amounting to $2.5 million.

  • Orchestra BioMed Holdings' Long-Term Investments changed 0.0% to $2.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.5 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $2.5 million for FY2024, which is 20.04% up from last year.
  • According to the latest figures from Q3 2025, Orchestra BioMed Holdings' Long-Term Investments is $2.5 million, which was down 0.0% from $2.5 million recorded in Q2 2025.
  • Over the past 5 years, Orchestra BioMed Holdings' Long-Term Investments peaked at $160.2 million during Q2 2022, and registered a low of $2.5 million during Q4 2022.
  • Its 4-year average for Long-Term Investments is $27.9 million, with a median of $2.5 million in 2024.
  • Per our database at Business Quant, Orchestra BioMed Holdings' Long-Term Investments plummeted by 9844.3% in 2023 and then rose by 20.04% in 2024.
  • Orchestra BioMed Holdings' Long-Term Investments (Quarter) stood at $2.5 million in 2022, then changed by 0.0% to $2.5 million in 2023, then rose by 0.2% to $2.5 million in 2024, then changed by 0.0% to $2.5 million in 2025.
  • Its Long-Term Investments stands at $2.5 million for Q3 2025, versus $2.5 million for Q2 2025 and $2.5 million for Q1 2025.